发明名称 Antimicrobial treatment for herpes simplex virus and other infectious diseases
摘要 A composition for treating microbial infections comprises antimicrobial isolates from at least a part of the following plants; Echinacea purpurea, E. angustifolia, E. pallidae, E. vegetalis, E. atribactilus, Pimpinella anisum, myroxylon, arctostaphylox, carum, capsicum, Eugenia mytacea, coriandrum, inula, allium, gentiana, juniperus, calendula, origanum, mentha labiate, commiphora, plantago, rosmarinus, ruta, laptisa, artemisa, sage, mentha, parthenium, integrifolium, eucalyptus, asteriacea and their cultivars. Also claimed is a method for treating herpes simplex or other infectious disease, by topical application of a composition containing 2-90 % of a phytochemical concentrate of E. purpurea and E. angustifolia, containing echinacen; echinacen B; echinaceine; echinacoside; caffeic acid ester; echinolone; enzymes; glucuronic acid; inulin; inuloid; pentadecadiene; polyacetylene compounds; polysaccharides; arabinogalactan; rhamnose; tannins; PSI (a 4-O-methylglucoronoarabinoxylan, Mr 35kD) and PS II (an acid rhaminoarabinogalactan, Mr 450 kD), cynarin; 1,5-di-O-caffeoylquinic acid, chicoric acid; 2,3-O-di caffeoyltartaric acid; borneol; bornyl acetate; pentadeca-8(Z) en-zone; germacrene D; caryophyllene; caryophyllene epoxide; anthocyanin, pyrolizidine alkaloid, lipophilic amide; isobutylamide; polyacetylene; anthocyanin; 3-O-B-D glucopyranoside; 3-O-(6-O-malonyl-B-D-glucopyranoside); tussilagine; isotussilagine; isomeric dodeca-isobutylamide; tetraenoic acid; and/or carophylenes; and 0.005 - 0.8 % quat. ammonium salt surfactants comprising alkyl dimethylbenzylammonium chloride, dimethylbenzylammonium chloride, benzalkonium halide, alkylbenzyldimethyl ammonium chloride, dialkyldimethyl ammonium chloride, diisobutylphenoxyethoxyethyl dimethylammonium chloride and o-benzyl-p-chlorophenol; and sterile water in ratio water to phytochemical concentrate and surfactant of 2-100:1. The composition is maintained on the infected area for 1-30 hours, during which period the physical symptoms are substantially resolved.
申请公布号 OA10917(A) 申请公布日期 2003.02.21
申请号 OA19989800215 申请日期 1998.11.06
申请人 MERYL SQUIRES 发明人 MERYL SQUIRES
分类号 A61K45/00;A01N33/12;A01N65/00;A01N65/08;A01N65/10;A01N65/22;A01N65/28;A01N65/38;A01N65/42;A01P3/00;A61K;A61K9/14;A61K31/13;A61K31/14;A61K31/19;A61K31/195;A61K31/198;A61K36/00;A61K36/28;A61K36/328;A61K36/534;A61K36/537;A61K36/61;A61K36/68;A61K36/8962;A61K38/27;A61K38/28;A61K39/385;A61P31/12;A61P31/22;(IPC1-7):A61K35/78 主分类号 A61K45/00
代理机构 代理人
主权项
地址